Bard Hernia Mesh Settlement 2026 | Payout Amounts, Eligibility & Legal Updates

The Bard Hernia Mesh Settlement in 2026 marks a major turning point for thousands of patients seeking compensation for injuries linked to Bard’s mesh implants. After years of litigation, negotiations, and individual case evaluations, claimants now have clearer guidance on potential payout amounts, eligibility standards, and what evidence strengthens a claim. This page explains how the settlement works, what factors influence compensation, and the latest legal developments shaping the future of the litigation. Whether you’re considering a claim, waiting for updates, or trying to understand where your case fits into the process, this guide breaks down every essential detail in straightforward terms. You’ll learn what to expect next and how remaining claims may move forward throughout 2026.

What the Bard Hernia Mesh Lawsuit Is About?

The Bard hernia mesh lawsuit centers on claims that certain hernia mesh products made by C. R. Bard and its subsidiary Davol were not safe for patients. These devices were used in hernia repair surgeries and were meant to strengthen the abdominal wall. Many patients argue that the mesh was designed with materials that can break down inside the body or cause strong inflammatory reactions. As a result, people say they have suffered problems like severe pain, infections, mesh movement, scar tissue, bowel issues, and hernia recurrence. In many cases, patients needed additional surgeries to remove the mesh or correct complications.

The lawsuits also claim that Bard knew or should have known about these risks but did not properly warn doctors or patients. People filing cases say the mesh’s design and coating did not perform as intended once inside the body. The coating was supposed to protect organs while healing, but is alleged to dissolve too quickly, leaving raw mesh exposed to tissues. This can lead to irritation, damage to nearby organs, and long-term health problems. Many lawsuits argue that Bard failed to test the product thoroughly or ignored signs that the mesh could cause harm.

Because thousands of people reported similar injuries, the cases were grouped together in a federal multidistrict litigation. This allows the court to handle common questions about defects and warnings in a more organized way. Some early trials were used to understand how juries might respond to the evidence. Settlement discussions have taken place over time, and many patients are seeking compensation for medical bills, pain, lost income, and the impact the injuries have had on their daily lives.

Timeline of the Bard Hernia Mesh Litigation

Before diving into the specifics of the Bard hernia mesh class action lawsuits, let’s first cover what brought most of you here – the latest updates, developments, and key news in the ongoing hernia mesh litigation.

September 1, 2025 – Court Activates Settlement Infrastructure Through QSF

The court overseeing MDL 2846 has officially moved into the implementation stage. A Qualified Settlement Fund has now been created to handle payments under the global settlement framework. Settlement money has been placed into a dedicated escrow account managed by Wells Fargo, with special masters and lien administrators supervising the process. This setup is essential for resolving government healthcare liens and organizing structured payouts. Although much of this work happens behind the scenes, it directly affects how smoothly and quickly claimants can receive their compensation.

June 12, 2025 – Case Numbers Shift Slightly as Post Settlement Activity Continues

The MDL experienced a minor reduction in active filings, with 24,074 cases pending on June 1, down by four from the previous month. This small change does not signal inactivity. Instead, it reflects the typical movement that follows a major settlement, where some claims are dismissed while others continue to be added. Even though a significant portion of the docket was resolved last year, new filings are still emerging, especially from individuals experiencing delayed complications or those who did not participate in the earlier settlement. This pattern of outgoing and incoming cases shows the MDL is in its later stage, yet still requires considerable effort before closure. The court remains active to address unresolved claims and manage a dwindling but ongoing flow of new lawsuits.

May 29, 2025 – Expected Timeline for Receiving Settlement Payments

Many plaintiffs want to know when they will receive their Bard hernia mesh settlement funds. There is no exact date available yet. Some faster, simplified claims may be paid sometime in 2025, but more complex cases are expected to take longer and may extend past the end of the year. The timing will depend on administrative reviews, lien resolution, and the pace at which individual claims are processed.

May 15, 2025 – Key Highlights of the Bard Hernia Mesh Settlement

The current settlement structure provides a broad overview of where the litigation stands. Roughly 38,000 lawsuits have been resolved to date. The total settlement value is expected to surpass one billion dollars. The defendant in these cases is Becton, Dickinson and Company, which owns C.R. Bard. Settlement distribution is being handled by special masters appointed by both federal and state courts. Payouts are planned to begin in 2025 and will continue over several years as claims are reviewed and finalized.

Compensation Tiers

The settlement offers three main payment categories based on the seriousness of a claimant’s injuries and the amount of medical intervention required.

• Quick Pay Level One is meant for individuals who filed a claim but do not meet the criteria for a recognized injury. This level provides a small, fixed payment of $2,500 and is designed for fast processing with minimal documentation.
• Quick Pay Level Two applies to people who experienced mild to moderate complications, often involving one corrective procedure. These claimants may receive around $25,000, reflecting a higher degree of harm while still allowing for a streamlined review.
• Traditional Compensation is reserved for those who suffered the most significant complications. This group includes individuals who underwent multiple surgeries or developed long-lasting health problems. Payments for these cases generally range from $60,000 to over $100,000, depending on the severity and documented medical impact.

Additional Details

The average payout for most traditional claims generally falls between $60,000 and $100,000, with the highest amounts reserved for people who experienced the most serious complications. For those in the traditional compensation path, payments are calculated through a points system that weighs the level of injury, medical treatments, and other qualifying factors. Claimants still have the option to opt out of the settlement and continue with their own individual lawsuit, but trial scheduling for those cases may not occur until 2029 or even later. All payments will be handled through a dedicated qualified settlement fund that was created to organize and distribute compensation in an orderly way.

May 1, 2025 – MDL Grows as New Claims Fall Outside Earlier Settlement

The Bard hernia mesh litigation continues to expand despite the large settlement reached last year. In the past month alone, 411 additional lawsuits were added, bringing the total number of active cases to 24,078. Because the original settlement only applied to older filings, many of the more recent claims were never part of that agreement. As a result, a new wave of plaintiffs is now waiting for a path forward. There is increasing discussion about a potential second settlement phase that may address these later filings, and many hope that any future offer will be stronger than the prior deal.

December 2, 2024 – Court Introduces New Settlement Program With Long Wait Ahead

A fresh case management order has launched a structured resolution system known as the Intensive Settlement Process. Two Special Masters, Ellen K. Reisman and John Jackson, have been appointed to supervise the framework, assist with negotiations, and provide routine updates to the court. While this system is intended to organize and streamline remaining claims, its timeline is lengthy. The program will not begin until January 2027, which means plaintiffs will face a significant period of inactivity before settlement efforts start. The process will run until all claims are reviewed, but anyone still without a resolution by June 2029 may step out of the program and move forward with litigation. For many claimants hoping for progress sooner, this extended schedule is likely to feel very discouraging.

October 8, 2024 – Court Sets New Rules for Cases With Unresponsive Plaintiffs

The MDL judge has introduced a new set of rules to address situations where attorneys can no longer reach their clients. The recent settlement activity has increased pressure to keep the docket organized, and the court wants to ensure that inactive cases do not slow down the process. Under this updated procedure, lawyers who have made repeated attempts to contact their clients may request that these cases be dismissed through a joint filing that also serves as their formal withdrawal from the case. This approach keeps the docket moving while still protecting the ability of plaintiffs to return if they reestablish communication.

The order outlines several important points. Cases dismissed under this rule will be closed without prejudice, giving plaintiffs a year to refile in the MDL. If they return within that period, their case will keep the original filing date, which helps preserve legal deadlines. Attorneys who withdraw through this process will no longer have obligations to clients they cannot reach. If a plaintiff does not refile within the one-year allowance, the defendants may ask the court to dismiss the case permanently, which would prevent it from being reopened. Any case that is refiled will still need to comply with the earlier case management orders, including those dealing with docket control and temporary pauses in proceedings.

October 2, 2024 – Settlement Reached, Payout Details Pending

A settlement has now been reached, marking a major turning point in the litigation. However, two key questions remain unanswered for plaintiffs: how much compensation they will receive and how long it will take for payments to begin. Those details will only become clear once the full settlement framework is released.

What is known so far is that payments will not arrive all at once. According to the company’s announcement, the settlement funds will be distributed over several years. This means some individuals may see their first checks in 2025, while others may wait longer depending on claim reviews, documentation, and the pace of the payout schedule. You can read the company’s statement here: BD Settlement Announcement.

September 16, 2024 – Substitution Request Highlights Slow Movement in MDL

A new filing has appeared on the MDL docket, something that has become increasingly uncommon. Lawyers for the plaintiffs have asked the court to permit a surviving spouse to step in as the new plaintiff after the original claimant passed away. The couple had filed the lawsuit together, and the request ensures that the case can continue despite the husband’s death.

Outside of this procedural update, the litigation remains largely in the same waiting phase. The judge continues to allow both sides time to shape a potential settlement structure, showing no urgency to send the remaining cases back to their home courts. A response is still pending on a previously filed motion, and Bard’s position on the matter will be closely watched.

September 4, 2024 – Family Pushes to Leave the MDL Amid Health and Delay Concerns

A frustrated family has asked the court to remove their lawsuit from the MDL and return it to federal court in Arizona, where it was originally filed. Their wrongful death case, involving injuries linked to the Bard Composix Kugel Hernia Patch, has seen no meaningful progress, and the extended delay has taken an emotional toll.

The urgency behind their request stems from the serious health decline of one of the plaintiffs, who is facing a recurrence of cancer. With their condition worsening, the family fears that time is running out and believes the case needs to move more quickly than the MDL’s slow pace allows.

They argue that remaining in the MDL no longer serves their interests, pointing to the absence of upcoming discovery, the cancellation of a fourth bellwether trial, and the stalled settlement discussions. By returning to Arizona, they hope to use the extensive discovery already completed and push their case forward independently, with the goal of achieving a resolution sooner rather than later.

July 5, 2024 – Court Issues Stay as Signs of a Settlement Emerge

Two major filings were entered today. The first establishes a pause on all active hernia mesh cases in the MDL. This pause can be lifted only for individuals who decide not to participate in the anticipated Master Settlement Agreement, indicating that such an agreement is in place or close to it.

A second order lays out the initial obligations for claimants who choose to opt out of the settlement. While the full terms of the deal have not been released, these filings make it clear that a settlement framework exists. More updates are expected once the details become public.

July 1, 2024 – Surge in Filings Ahead of Expected Settlement Window

June turned into a race among hernia mesh attorneys to file as many cases as possible. A total of 745 new lawsuits were added in just one month. The reason for this rush is simple: no one knows exactly where the cutoff will fall for eligibility in the anticipated settlement, but filing a lawsuit now is the safest way to ensure inclusion.

June 30, 2024 – Confidential Settlements Confirm Behind-the-Scenes Progress

A joint motion filed by two law firms and Bard seeks to seal the terms of their hernia mesh settlement agreements. Their position is that making the terms public would give other lawyers leverage in ongoing negotiations. This filing confirms what had only been whispered until now: some firms have already reached deals with Bard. Alongside this, widespread talk in the legal community suggests that a broader settlement is essentially complete and may be officially announced at any moment.

June 25, 2024 – Continued Quiet as Settlement Rumors Circulate

The docket has seen no new entries since May 30. Although the court’s activity remains minimal, discussion of a large-scale settlement continues to dominate the background. Nothing concrete has surfaced yet, keeping the situation in rumor territory.

May 16, 2024 – New Claims Still Being Accepted but Uncertain for How Long

After a short pause, firms are once again taking on new Bard hernia mesh claims. It is unclear how much longer new cases will be viable, and waiting could result in missing the window for inclusion in any future settlement. Potential claimants are being urged not to delay.

April 29, 2024 – Near Silence on the Docket as Speculation Grows

The MDL has been extremely quiet, with the last recorded entry dated April 12. Many observers believe that this lack of activity indicates that a settlement may be nearing announcement, although nothing official has been released so far.

April 5, 2024 – Minimal Activity on the MDL Docket

The Bard hernia mesh MDL continues to see almost no movement. A single case from West Virginia was recently transferred into the MDL, and one attorney stepped down from a leadership role, but neither development has anything to do with settlement talks. Aside from that, the docket has remained largely unchanged.

Although people are still talking about the possibility of an upcoming settlement announcement, there is no verified information. A small negotiation team continues to handle discussions, and they are keeping all details confidential until an agreement is officially finalized.

March 5, 2024 – Court Sets New Mediation Schedule

Judge Sargus released a new order establishing the next phase of mediation in the Bard hernia mesh MDL. The plan calls for in-person sessions on March 25 and March 26, 2024, after being rescheduled from earlier dates. John Jackson will serve as the mediator and oversee the discussions. The judge has also made it clear that if the parties cannot reach a settlement by May 24, 2024, they must submit a detailed proposal that outlines how they intend to move the litigation forward.

March 3, 2024 – Case Count Continues to Rise

The MDL has reached a new milestone with 21,262 hernia mesh lawsuits now on file. The growing volume of claims reflects the continued scale and complexity of this litigation.

February 20, 2024 – Judge Launches New Mediation Framework

The court has introduced CMO 51, which outlines a fresh mediation structure aimed at pushing the Bard hernia mesh litigation toward resolution. The plan calls for in-person negotiation sessions on March 4 and March 5, 2024, with the option for additional meetings if the mediator believes they are necessary. These dates were later shifted, as reflected in the March 5 update.

If the parties cannot reach a deal by May 24, 2024, they must inform the court and submit a joint proposal by June 24, 2024, detailing how the litigation should proceed. This likely signals that unresolved cases may eventually be sent back to their home federal courts for trial. The mediation effort will include representatives from both sides, members of the Plaintiffs’ Negotiation Committee, and mediator John Jackson, who has been appointed by the court to lead the process.

February 5, 2024 – Court Declines Fourth Bellwether and Addresses Case Management

A new case management order, CMO 50, was issued addressing two major issues: whether to proceed with a fourth bellwether trial in the Bard hernia mesh MDL and how to handle potential remands of remaining cases.

Fourth Bellwether Trial

The court determined that a fourth bellwether trial will not be held. After three prior trials involving different products and legal issues, the judge concluded that another trial would not significantly contribute additional guidance for settlement or litigation strategy. The Bryan case, which had been under consideration as the next bellwether, will therefore not move forward.

Future Case Management and Remand

The plaintiffs requested that the remaining cases be structured for remand to their original federal courts, along with a detailed plan for discovery and trial scheduling. The court denied the request, stating that it was premature. The judge emphasized that efforts remain focused on achieving a global settlement before initiating widespread remands and found the proposed schedule too accelerated to be practical at this stage of the litigation.

February 1, 2024 – Court Declines Bard’s Request for a New Trial in Stinson

The court issued a clear decision declining Bard’s attempt to secure a new trial in the Stinson case, finding no merit in any of the arguments raised. First, the judge rejected Bard’s claim that the PerFix Plug’s Instructions for Use were adequately supported by testimony. The court noted that Bard focused on attacking witness credibility rather than addressing the underlying evidence, which is not the standard for overturning a verdict. Second, the judge found sufficient evidence of causation despite Bard’s reliance on the learned intermediary doctrine. Testimony showed that the implanting surgeon expected warnings tailored specifically to the device, raising legitimate questions about whether inadequate warnings played a role in the plaintiff’s injuries. Finally, the court dismissed Bard’s argument that the negligence verdict should fail alongside strict liability, noting that the jury’s finding on failure to warn stood independently, and Bard offered no new facts to justify revisiting prior rulings.

December 1, 2023 – Fourth Bellwether Trial Scheduled for April 2024

The court has scheduled the fourth bellwether trial in the Bard hernia mesh litigation for April 8, 2024. This case, brought by Jacob Bryan of Florida, centers on complications linked to the Bard 3DMax mesh. Bryan claims that the product’s design caused it to fail, which required surgical removal in 2017 and left him with lasting pain and injuries. The upcoming trial represents another important test of the claims raised throughout the MDL, although it would be strategically beneficial for plaintiffs if these trials were scheduled closer together to maintain consistent pressure on the defendant.

November 9, 2023 – Plaintiffs Secure Another Win in Stinson

A new verdict has been issued in the Stinson case, awarding the plaintiff $500,000. Bard presented a strong lineup of expert witnesses, the kind that typically command significant credibility, yet the jury ultimately sided with the plaintiff’s evidence and arguments. This outcome marks Bard’s third consecutive loss in the bellwether trials, further shaping the trajectory of the ongoing litigation.

Below is a summary of the major Bard hernia mesh bellwether outcomes across the MDL and related jurisdictions. These results have shaped the negotiations and expectations surrounding the settlement process, reflecting both plaintiff victories and one defense win:

• Johns – July 2021 – MDL (Ohio): Defense verdict
• Milanesi – April 2022 – MDL (Ohio): $250,000 verdict
• Trevino – August 2022 – Rhode Island: $4,800,000 verdict
• Stinson – November 2023 – MDL (Ohio): $500,000 verdict

October 26, 2023 – Plaintiff Continues Case in Stinson Trial

The plaintiff’s case continued on Day 9 of the trial. He had previously undergone a right inguinal hernia repair using an Extra Large PerFix Plug mesh. Two years later, he required another surgery due to persistent right groin pain. During the procedure, the surgeon discovered extensive scarring and a bundled ball of mesh measuring approximately 2.5 cm, which was challenging to remove. After removal, the surgeon repaired the hernia using Bard Marlex Mesh.

October 31, 2023 – Defense Case Begins with Expert Testimony

The defense began presenting its case. BJ J. Pomerants, MD, testified that the plaintiff’s pre-existing injuries and conditions affected his perception of groin pain both before and after the implant surgery.

November 1, 2023 – Continued Expert Testimony

Dr. Pomerants continued his testimony, including direct, cross, and redirect examinations. His testimony addressed the plaintiff’s medical history and its relation to reported pain.

November 3, 2023 – Explanting Surgeon Testifies

Dr. Radke, the explanting surgeon, provided testimony by videotape as part of the defense case.

June 5, 2023 Update – Bard Requests Postponement of Stinson Trial

Bard requested that the Stinson bellwether trial be postponed, stating that the plaintiff’s injuries have escalated and that the case may no longer serve as an effective bellwether trial. The court will review this request as part of ongoing case management in MDL 2846.

June 1, 2023 Update – Vaughn Case Included in Bard MDL

In Vaughn et al. v. Kentuckiana Surgical Specialists, P.S.C., the plaintiff filed a hernia mesh lawsuit in the Southern District of Ohio after originally filing in the Western District of Kentucky and requested to remain outside of MDL 2846. The MDL Panel determined that the case shares common factual questions with other Bard hernia mesh cases, focusing on alleged defects in Bard polypropylene mesh products that may cause complications such as adhesions, organ damage, and infections.

May 25, 2023 – Rhode Island Judge Adjusts Trevino Verdict

The Rhode Island Superior Court reduced the Trevino verdict by $250,000 while leaving $4.55 million intact in post-trial motions. The court upheld the majority of the jury’s award and affirmed key rulings that had previously been challenged by Bard.

May 13, 2023 – Motion Filed on Workers’ Compensation Evidence

A motion was filed in the Stinson case regarding the admissibility of evidence related to the plaintiff’s workers’ compensation claim. Bard sought to admit information about the award and amount received, while the plaintiff argued under the collateral source rule that such evidence should be excluded, as it could improperly influence the jury and holds no evidentiary value.

March 20, 2023 – Settlement Possibility in Stinson Case

The Stinson trial, scheduled to serve as the third bellwether case in MDL 2846 on May 15, 2023, has been delayed without objection from the plaintiff. Despite the denial of a summary judgment motion, Bard requested a postponement, which was granted by the MDL judge. A new trial date has not yet been set, suggesting the possibility of a settlement.

March 15, 2023 – Stinson Trial Scheduled for May 15, 2023

The Stinson trial is scheduled for May 15, 2023. The plaintiff’s claims include allegations that Bard’s polypropylene hernia mesh caused complications due to design defects. The court allowed the design defect claim, punitive damages, negligence, and warranty claims to proceed to trial while granting judgment for the defendants on other claims. The trial is the third bellwether in the MDL, which has over 18,000 pending cases.

February 9, 2023 – Schedule Set for Third Bellwether Trial

The Bard MDL judge issued an order establishing the schedule for the third hernia mesh bellwether trial, Stinson v. C.R. Bard et al. Pretrial conferences are set for May 2 and 3, with the trial beginning on May 15, 2023. Both parties must submit final witness lists this month, and lawyers are required to propose dates for a fourth bellwether trial later in the year.

January 18, 2023 – MDL Case Count Reaches 18,403

There are 18,403 Bard hernia mesh lawsuits pending in the MDL, reflecting an increase of 176 cases over the past 30 days. This represents the highest percentage increase among mass tort MDLs during that period, showing a sustained rise in filings as the next bellwether trial in May approaches.

January 2, 2022 – Rhode Island Sees New Lawsuits Filed

The Rhode Island state court, the venue for the Trevino case, continues to receive new Bard hernia mesh lawsuits. Since Christmas, 23 additional cases were filed in the state, adding to the ongoing accumulation of claims in this jurisdiction.

September 5, 2022 – Plastic Resin Issues Highlighted in Trevino Trial

During the Trevino trial, it emerged that C.R. Bard continued using a plastic resin in its mesh products despite warnings from the supplier that it was unsafe for that purpose. The material, Pro-fax 6523 from LyondellBasell, was the cheapest option meeting specifications but explicitly prohibited for permanent implantation. Bard’s continued use of this plastic in hernia mesh products represents a significant point highlighted by plaintiff attorneys and may influence ongoing litigation.

August 29, 2022 – Rhode Island Jury Awards $4.8 Million in Trevino Case

The Rhode Island jury awarded Paul Trevino $4.8 million after he alleged that C.R. Bard’s Ventralex hernia patch eroded into his bowel. The jury found the design defective and ruled that Bard failed to warn of the risks. This verdict is likely to influence the settlement value of other Bard hernia mesh cases.

August 26, 2022 – Trevino Case Focuses on PET Ring Risks

In Trevino v. Bard, the plaintiff claimed that the PET ring in the Ventralex Mesh was prone to breaking or buckling, increasing the risk of serious, permanent injuries. The plaintiff argued that Bard knew or should have known about these risks yet intended for the product to be implanted as used by the plaintiff and her physician.

June 14, 2022 – Milanesi Responds to Bard’s JMOL Motion

Plaintiff Antonio Milanesi filed a response to Bard’s post-verdict motion for judgment as a matter of law. Milanesi highlighted that Bard’s arguments had already been rejected twice previously, including during summary judgment and the pre-verdict JMOL. The response also confirmed that the plaintiff met the standard of proof for product defect under Florida law with expert testimony regarding Ventralex mesh issues.

May 24, 2022 – Milanesi Lawyers File Motions After $255,000 Verdict

Following the $255,000 verdict in the Milanesi case, both sides filed post-trial motions. Defendants requested judgment as a matter of law, arguing the plaintiffs did not prove causation or design defect under Florida law. The plaintiffs’ attorneys filed a motion for a new trial on damages only, claiming the jury was not properly instructed on the defense’s burden regarding mitigating damages. Both sides were scheduled to file responses the next day.

May 23, 2022 – MDL-2846 Case Count and Bellwether Trial Updates

As of May 16, the Bard hernia mesh MDL had 18,803 active cases. The second bellwether trial concluded with a $250,000 verdict over a month prior, but a date for the third bellwether trial had not yet been set. Only three new cases were added in May. Plaintiffs and lawyers continued to hope for reasonable settlement offers, though no concrete developments were reported.

May 3, 2022 – Third Bellwether Trial Still Pending

Updates for hernia mesh victims remained limited as no new trial date had been set. Lawyers anticipated the third bellwether trial could take place in October 2022. Comparisons to the settled Johnson & Johnson Ethicon Physiomesh cases suggested possible influence on Bard settlements, though Bard claims differed due to the absence of a full recall, making resolution more complex.

April 16, 2022 – Milanesi Trial Verdict

The jury awarded $250,000 to Mr. Milanesi and $5,000 to his wife, who brought a loss of consortium claim. The verdict recognized a defective design count. Had each plaintiff received a similar settlement, Bard would have faced a $4 billion payout for all federal hernia mesh lawsuits, though many claims involved more severe injuries than in the Milanesi case.

Read about the Paragard IUD Lawsuit Updates

Health Risks & Complications Linked to Bard Hernia Mesh

Patients who received Bard hernia mesh have reported a wide range of health problems that often begin months or even years after surgery. One of the most common issues is chronic pain, which can become constant and affect daily activities. Many people also develop infections around the surgical site. These infections can be difficult to treat because bacteria may attach to the mesh, making antibiotics less effective. Some patients also experience swelling, redness, or fever as the infection spreads.

Another major concern is the way the mesh can interact with internal tissues. The coating on certain Bard mesh products may dissolve too quickly, which leaves the bare material in direct contact with organs. This can cause irritation, inflammation, or scar tissue that sticks to nearby structures. Some patients develop adhesions, where organs or tissues become stuck together. Others face mesh migration, which means the device no longer stays in place and may move into other areas of the abdomen. Migration can lead to bowel obstruction or punctures that require emergency treatment.

Many people also experience hernia recurrence because the mesh does not hold properly once complications begin. When the body reacts negatively to the mesh, the tissue may weaken, or the mesh may shrink or fold. In the most serious cases, patients need revision surgery to remove the damaged or infected mesh. This can be a complex procedure that carries its own risks. For some individuals, these complications have long-lasting effects on mobility, comfort, and overall quality of life.

Read about the Paraquat Parkinson Lawsuit Updates

Who Is Eligible for the Bard Hernia Mesh Settlement

Many patients want to know whether they qualify for the Bard hernia mesh settlement. The main requirements focus on the type of mesh used, the complications experienced, and whether the case is part of the ongoing litigation. Below are the key points that explain who may be eligible.

• You had a Bard or Davol hernia mesh implanted
Patients who received one of the approved Bard hernia mesh products during surgery may qualify to file a claim.

• You experienced complications linked to the mesh
Common qualifying problems include chronic pain, infections, adhesions, mesh movement, bowel issues, or hernia recurrence.

• You needed revision or removal surgery
Patients who require additional surgery to fix or remove the mesh often qualify for higher settlement tiers.

• You have medical records showing the mesh type and injuries
Documentation is needed to confirm both the mesh product and the complications that followed.

• Your case is part of the Bard hernia mesh litigation
Eligibility usually requires that the claim be filed within the settlement program and meet the court deadlines.

• You may still qualify even with minor injuries
Some settlement programs offer a quick pay option for patients who had a Bard mesh device but did not suffer severe complications.

How the Settlement Process Works: Filing & Medical Evidence

Understanding how to file a Bard hernia mesh claim and what medical evidence you need is important for anyone seeking settlement money. The process is structured and requires proper documentation to prove both the mesh used and the injuries that followed. The steps below explain how the settlement process usually works.

• Filing a claim with the settlement program
The first step is submitting a formal claim that includes your basic information, surgery details, and the type of Bard mesh implanted. This filing places your case into the settlement review system.

• Providing proof of mesh implantation
You must show medical records that clearly identify the Bard or Davol mesh product used in your hernia repair. Operative reports and product labels are often required.

• Submitting medical evidence of complications
To qualify for higher compensation levels, you need records showing problems such as pain, infections, mesh failure, bowel issues, or the need for revision surgery. Medical notes, diagnostic tests, and hospitalization records support these claims.

• Showing proof of revision or removal surgery if applicable
If you had additional surgeries to correct or remove the mesh, you must provide surgical reports and follow-up records. These cases usually fall into higher settlement tiers.

• Claim review by settlement administrators
Once all records are submitted, settlement reviewers examine your evidence and place your claim into a compensation category based on the severity of your injuries.

• Receiving an award amount or settlement offer
After review, you receive a settlement amount based on the tier your case qualifies for. You then choose whether to accept the payment.

Settlement Tiers & Payout Structure for Bard Hernia Mesh Cases

The Bard hernia mesh settlement uses a tier system to decide how much compensation each patient may receive. This system groups claims based on the type of injury, the seriousness of complications, and whether the person needed additional surgery. The goal is to make sure that people with the most severe problems receive higher payouts.

• Tier for minor or limited complications
Patients who experienced mild pain or minor issues that did not require further surgery may fall into the lowest tier. These cases usually receive the smallest payouts, but may also qualify for a quick pay option.

• Tier for moderate complications
This tier includes patients who had more noticeable medical problems, such as infections, mesh movement, or significant pain that affected daily life. These cases receive higher compensation because the complications required more treatment.

• Tier for severe injuries with revision surgery
People who needed one revision surgery to remove or repair the mesh are often placed in a higher payout category. Compensation is greater because the surgery shows clear damage linked to the mesh.

• Tier for multiple surgeries or serious long-term harm
The highest payouts are usually given to patients with major injuries, multiple revision surgeries, bowel damage, chronic disability, or complications that caused permanent changes in health. These cases show the most severe impact of the mesh failure.

• Factors that influence payout amounts
Settlement reviewers consider the type of mesh implanted, the severity of injuries, time spent in treatment, long-term medical needs, age, and how much the complications affect the person’s life.

Read about: Can You Sue Someone for Emotional Distress?

Legal Developments & Court Rulings in the Bard Mesh MDL

The Bard hernia mesh lawsuits were brought together into a multidistrict litigation so that thousands of similar cases could be handled in one federal court. This helped streamline the process and allowed the judge to oversee shared issues such as product design, medical evidence, and expert testimony. Over time, the court issued important rulings that shaped how the litigation moved forward. Decisions on which experts could testify and what scientific evidence was allowed played a major role in determining how strong each side’s arguments would be at trial.

As the MDL progressed, several bellwether trials were held to test the evidence. These early trials produced mixed results, with some victories for plaintiffs and some for the defense. The outcomes helped both sides understand the strengths and weaknesses of their cases and encouraged more serious settlement discussions. When negotiations became more active, the court issued orders that paused certain parts of the litigation so that the parties could focus on reaching an agreement.

Eventually, the court approved the structure for a global settlement that would resolve thousands of claims at once. A qualified settlement fund was created to organize the payouts and to place claims into specific injury categories. Throughout this process, the MDL judge has continued to supervise the settlement program and ensure that the claims are reviewed fairly and consistently. This combination of rulings, trials, and court oversight has guided the Bard mesh litigation toward a coordinated resolution.

What Comes Next for Remaining Bard Hernia Mesh Claims

Even after a large portion of Bard hernia mesh cases were settled, many claims remain active. These unresolved cases will go through an Intensive Settlement Process (ISP) overseen by court-appointed special masters. During this process, plaintiffs who have not reached a resolution will submit detailed settlement packages that include medical records, surgery reports, pathology results, and a demand for what they believe they should receive. For those whose cases don’t settle during these mediation sessions, the next step involves formal mediation with a special master in person.

If mediation does not resolve a case, claimants still have a path forward: they can continue with litigation under what the court calls “docket control orders.” That means their case could go back into active litigation rather than staying in the settlement process. The court has scheduled this settlement-mediation framework to run at least until mid-2029. After that, if some cases are still unresolved, those plaintiffs may opt out of the settlement track and go back to traditional litigation in their original courts.

Meanwhile, a Qualified Settlement Fund (QSF) has been established to manage the money for all approved Bard hernia mesh claims. This fund will be used to pay out plaintiffs based on the settlement tier they fall into, while also handling administrative costs and medical-lien obligations. The court and the special masters will monitor how the fund is distributed to make sure payments are fair and follow the agreed structure.

Read about the Average Settlement for Back and Neck Injury After a Car Accident

FAQs About the Bard Hernia Mesh Settlement